Ultrasound patterns of parathyroid glands in chronic hemodialysis patients with secondary hyperparathyroidism

American Journal of Nephrology

Volumn 28, Issue 4, 2008, Pages 589-597

  Vulpio, Carlo ^a   Bossola, Maurizio ^a   De Gaetano, Annamaria ^b   Maresca, Giulia ^b   Di Stasio, Enrico ^a   Spada, Pier Luigi ^a   Romitelli, Federica ^a   Luciani, Giovanna ^a   Castagneto, Marco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Istituto di Radiologia di Universita Cattolica del Sacro Cuore di Roma   (Italy)

Author keywords

Parathyroid glands; Parathyroidectomy; Ultrasonography; Uremic secondary hyperparathyroidism

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MALE; NODULAR HYPERPLASIA; ORGAN SIZE; PARATHYROID GLAND; PARATHYROIDECTOMY; PREDICTOR VARIABLE; PRIORITY JOURNAL; SCORING SYSTEM; SECONDARY HYPERPARATHYROIDISM; VASCULARIZATION;

FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MALE; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROIDECTOMY; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 45149096794     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000116875     Document Type: Article

References (48)

1. Solbiati L, Giangrande A, De Pra L, Cantù P, Ravetto C: Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism. Radiology 1985;155:607-610.
2. Martinoli C, Pretolesi F, Crespi G: Power Doppler sonography: clinical applications. Eur J Radiol 1998;27(suppl 2):S133-S140.
3. Mazzeo S, Caramella D, Lencioni R: Usefulness of echocolor Doppler in differentiating parathyroid lesions from other cervical masses. Eur Radiol 1997;7:90-95.
4. Lane MJ, Desser TS, Weigel RJ: Use of color and power Doppler sonography to identify feeding arteries associated with parathyroid adenomas. Am J Roentgenol 1998;171:819-823.
5. Wolf RJ, Cronan JJ, Monchik JM: Color Doppler sonography: an adjunctive technique in assessment of parathyroid adenomas. J Ultrasound Med 1994;13:303-308.
6. McCarron DA, Muther Rs, Lenfesty B, Bennett WM: Parathyroid function in persistent hyperparathyroidism: relationship to gland size. Kidney Int 1982;22:662-670.
7. Clark OH, Stark DA, Duh QY, Arnaud CD, Gooding GA: Value of high resolution realtime ultrasonography in secondary hyperparathyroidism. Am J Surg 1985;150:9-17.
8. Gooding AW, Clark OH: Use of color Dopp - ler imaging in the distinction between thyroid and parathyroid lesions. Am J Surg 1992;164:51-56.
9. Guillem P, Vlaeminck-Guillem V, Dracon M, Noel C, Cussac JF, Huglo D, Proye C: Are preoperative examinations useful in the management of patients with renal hyperparathyroidism? Ann Chir 2006;131:27-33.
10. Perie S, Fessi H, Tassart M, Younsi N, Poli I, St Guily JL, Talbot JN: Usefulness of combination of high-resolution ultrasonography and dual-phase dual isotope iodine 123/technetium Tc99m sestamibi scintigraphy for the preoperative localization of hyperplastic parathyroid glands in renal hyperparathyroidism. Am J Kidney Dis 2005;45:344-352.
11. Fukagawa M, Kitaoka M, Yi H, Fukuda N, Matsumoto T, Ogata E, Kurokawa K: Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patient. Nephron 1994;68:221-228.
12. Fukagawa M, Kitaoka M, Kurokawa K: Value of parathyroid sonography in secondary hyperparathyroidism. Nephrol Dial Transplant 1997;12:2461.
13. Fukagawa M, Kitaoka M, Inazawa T, Kurokawa K: Imaging of the parathyroid in chronic renal failure: diagnostic and therapeutic aspects. Curr Opin Nephrol Hypertens 1997;6:349-355.
14. Katoh N, Nakayama M, Shigematsu T, Yamamoto H, Sano K, Saito I, Nakano I, Kasai K, Kubo H, Sakai S, Kawaguchi Y, Hosoya T: Presence of sonographically detectable parathyroid glands can predict resistance to oral pulsed-dose calcitriol treatment of secondary hyperparathyroidism. Am J Kidney Dis 2000;35:465-468.
15. Okuno S, Ishimura E, Kitatani K, Chou H, Nagasue K, Maekawa K, Izumotani K, Yamakawa T, Imanishi Y, Shoji T, Inaba M, Nishizawa Y: Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism. Nephrol Dial Transplant 2003;18:2613-2621.
16. Onoda N, Kurihara S, Sakurai Y, Owada K, Osono E, Adachi H, Suga M, Yoneshima H: Evaluation of blood supply of the parathyroid glands in secondary hyperparathyroidism compared to histopathology. Nephrol Dial Transplant 2003;18(suppl 3):iii34-iii37.
17. Pavlovic D, Brzac HT: Prevention and treatment of secondary hyperparathyroidism: Still a challenge for the nephrologist? Nephrol Dial Transplant 2003;18(suppl 5):v45-v46.
18. Ahuja AT, Wong KT, Ching ASC, Fung MK, Lau JYW, Yuen EHY, King AD: Imaging for primary hyperparathyroidism - what beginners should know. Clin Radiol 2004;59:967-976.
19. Senschenkov A, Staren ED: Ultrasound in head and neck surgery: thyroid, parathyroid and cervical lymph nodes. Surg Clin N Am 2004;84:973-1000.
20. Onoda N, Kurohara S, Yoneshima H: Usefulness of ultrasonographic power-Doppler imaging of parathyroid hyperplasia in renal hyperparathyroidism. J Am Soc Nephrol 1998;9:569-571.
21. Tominaga Y, Tanaka Y, Sato K, Nagasaka T, Takagi H: Histology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 1997;13:78-86.
22. Kakuta T, Fukagawa M, Fujisaki T, et al: Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients. Am J Kidney Dis 1999;33:109-119.
23. Onoda N, Kashiwagi T, Nakamura T, Niitsu Y, Omata M, Kurihara S: Parathyroid interventions for secondary hyperparathyroidism in hemodialyzed patients. Ther Apher Dial 2005;9(suppl):S11-S15.
24. Fukagawa M, Kitaoka M, Tominaga Y, Akizawa T, Kurokawa K: Selective percutaneous ethanol injection therapy (PEIT) of parathyroid in chronic dialysis patients - the Japanese strategy. Nephrol Dial Transplant 1999;14:2574-2577.
25. Kitoaka M: Ultrasonographic diagnosis of parathyroid glands and percutaneous ethanol injection therapy. Nephrol Dial Transplant 2003;18(suppl 3):iii27-iii30.
26. Ritz E: Which is the preferred treatment of advanced hyperparathyroidism in a renal patient? II. Early parathyroidectomy should be considered as the first choice. Nephrol Dial Transplant 1994;9:1819-1821.
27. Malberti F, Corradi B, Cosci P, Calliada F, Marcelli D, Imbasciati E: Long term effect of intravenous calcitriol therapy on the control of secondary hyperparathyroidism. Am J Kidney Dis 1996;28:704-712.
28. Indridason OS, Heath H 3rd, Khosla S, Yohay DA, Quarles LD: Nonsuppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism. Kidney Int 1996;50:1663-1671.
29. Rodriguez M, Canalejo A, Garfia B, Aguilera E, Almaden Y: Pathogenesis of refractory hyperparathyroidism. Kidney Int 2002;61(suppl 80):155-160.
30. Fukuda N, Tanaka H, Fukagawa M, Kurokawa K, Seino Y: Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993;92:1436-1443.
31. Parfitt AM: The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int 1997;52:3-9.
32. Drueke TB: Cell biology of parathyroid gland hyperplasia in chronic renal failure. J Am Soc Nephrol 2000;11:1141-1152.
33. Fukagawa M, Nakanishi S, Kazama JJ: Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease. Kidney Int 2006;70:S3-S7.
34. Lewin E, Olgaard K: Influence of parathyroid mass on the regulation of PTH secretion. Kidney Int 2006;70:S16-S21.
35. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:S1-S202.
36. Indridason S, Quarles LD; The Durham Renal Osteodystrophy Study Group: Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients. Kidney Int 2000;57:282-292.
37. Salem MM: Hyperparathyroidism in the hemodialysis population: a survey of 612 patients. Am J Kidney Dis 1997;29:862-865.
38. Nakanishi S, Yano S, Nomura R, Tsukamoto T, Shimizu Y, Shin J, Fukagawa M: Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism. Nephrol Dial Transplant 2003;18(suppl 3):iii47-iii49.
39. Tominaga Y, Inaguma D, Matsuoka S, Tahara H, Kukita K, Kurihara S, Onoda N, Tsuruta Y, Tsutsui S, Ohta K, Kuwahara M, Tanaka M, Nishizawa Y: Is the volume of the parathyroid gland a predictor of maxacalcitol response in advanced secondary hyperparathyroidism? Ther Apher Dial 2006;10:761-771.
40. Moe S, Chertow GM, Coburn JW, Quarles D, Goodman W, Block GA, Drueke TB, Cunningham J, Sherrard DJ, McCarry LC, Olson K, Turner SA, Martin MJ: Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int 2005;67:760-777.
41. Loevner LA: Imaging of the parathyroid glands. Semin Ultrasound CT MR 1996:17:563-575.
42. Kamaya A, Quon A, Jeffrey RB: Sonography of the abnormal parathyroid gland. Ultrasound Q 2006;22:253-262.
43. Barraclough BM, Barraclough BH: Ultrasound of the thyroid and parathyroid glands. World J Surg 2000;24:158-165.
44. Varsamidis K, Varsamidou E, Mavropoulos G: Color Doppler sonography in the detection of parathyroid adenomas. Head Neck 1999;21:648-651.
45. Fugakawa M, Kazama JJ, Shigematsu T: Management of patients with advanced secondary hyperparathyroidism - the Japanese approach. Nephrol Dial Transplant 2002;17:1553-1557.
46. Lagalla R, Caruso G, Finazzo M: Monitoring treatment response with color and power Doppler. Eur J Radiol 1998;28:S149-S156.
47. Pretolesi F, Silvestri E, Di Maio G, Martinoli C, Onetto F, Sala P, Derchi LE: US imaging and color-Doppler in patients undergoing inhibitory therapy with calcitriol for secondary hyperparathyroidism. Eur Radiol 1997;7:721-725.
48. Pavlovic D, Tomic Brzac H: US Evaluation of parathyroid hyperplasia. ScientificWorld-Journal 2006;6:1599-1608.